Direct-to-consumer genomewide profiling [7]

New England Journal of Medicine

Volumn 364, Issue 21, 2011, Pages 2074-2075

  Salz, Talya ^a   Brewer, Noel T ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; BREATHING DISORDER; DIABETES MELLITUS; GENE EXPRESSION PROFILING; HEALTH HAZARD; HUMAN; LETTER; NERVOUSNESS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RATING SCALE; RISK FACTOR; SLEEP DISORDER; STRESS; SYMPTOMATOLOGY; WELLBEING;

EID: 79957502460     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1103048     Document Type: Letter

References (3)

1. Bloss CS, Schork NJ, Topol EJ. Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med 2011;364:524-34.
2. Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psychooncology 2010;19:1026-34.
3. Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 2003;56:52-60.